These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7866252)

  • 21. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new target for behavioural research--amphetamine misuse.
    Klee H
    Br J Addict; 1992 Mar; 87(3):439-46. PubMed ID: 1559042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with heroin users' AIDS risk-taking behaviours.
    Caplehorn JR; Saunders JB
    Aust J Public Health; 1993 Mar; 17(1):13-7. PubMed ID: 8357887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine use among injecting drug users.
    Seivewright N
    Addiction; 1994 Dec; 89(12):1701-3. PubMed ID: 7866255
    [No Abstract]   [Full Text] [Related]  

  • 25. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepine use in a rural general practice population.
    Lyndon RW; Russell JD
    Aust N Z J Psychiatry; 1988 Sep; 22(3):293-8. PubMed ID: 2902838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
    Topp L; Barker B; Degenhardt L
    Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug use patterns and mental health of regular amphetamine users during a reported 'heroin drought'.
    Baker A; Lee NK; Claire M; Lewin TJ; Grant T; Pohlman S; Saunders JB; Kay-Lambkin F; Constable P; Jenner L; Carr VJ
    Addiction; 2004 Jul; 99(7):875-84. PubMed ID: 15200583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone maintenance and the likelihood of risky needle-sharing.
    Caplehorn JR; Ross MW
    Int J Addict; 1995 May; 30(6):685-98. PubMed ID: 7657397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System.
    Darke S; Topp L; Ross J
    Drug Alcohol Rev; 2002 Mar; 21(1):27-32. PubMed ID: 12189001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent trends in benzodiazepine use by injecting drug users in Victoria and Tasmania.
    Fry CL; Bruno RB
    Drug Alcohol Rev; 2002 Dec; 21(4):363-7. PubMed ID: 12537706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the determinants of safe injecting and condom use among injecting drug users.
    Myers T; Millson M; Rigby J; Ennis M; Rankin J; Mindell W; Strathdee S
    Addiction; 1995 Feb; 90(2):217-26. PubMed ID: 7703815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzodiazepine use among young attendees of an Irish substance treatment center.
    Murphy KD; Byrne S; McCarthy S; Lambert S; Sahm LJ
    J Addict Med; 2014; 8(3):199-204. PubMed ID: 24662371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
    Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.
    Gossop M; Griffiths P; Powis B; Strang J
    AIDS Care; 1993; 5(2):159-68. PubMed ID: 8392383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic drug consumption and other factors associated with heroin overdose.
    Gutiérrez-Cebollada J; de la Torre R; Ortuño J; Garcés JM; Camí J
    Drug Alcohol Depend; 1994 Apr; 35(2):169-74. PubMed ID: 7914483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.